156 related articles for article (PubMed ID: 37055530)
1. Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation.
Xu YJ; Zeng K; Ren Y; Mao CY; Ye YH; Zhu XT; Sun ZY; Cao BY; Zhang ZB; Xu GQ; Huang ZQ; Mao XL
Acta Pharmacol Sin; 2023 Sep; 44(9):1920-1931. PubMed ID: 37055530
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis.
Sun T; Xu YJ; Jiang SY; Xu Z; Cao BY; Sethi G; Zeng YY; Kong Y; Mao XL
Acta Pharmacol Sin; 2021 Aug; 42(8):1338-1346. PubMed ID: 33184448
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
[TBL] [Abstract][Full Text] [Related]
5. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
Zhu H; Yan F; Yuan T; Qian M; Zhou T; Dai X; Cao J; Ying M; Dong X; He Q; Yang B
Cancer Res; 2020 Jun; 80(11):2204-2216. PubMed ID: 32217697
[TBL] [Abstract][Full Text] [Related]
6. Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.
Cao YF; Xie L; Tong BB; Chu MY; Shi WQ; Li X; He JZ; Wang SH; Wu ZY; Deng DX; Zheng YQ; Li ZM; Xu XE; Liao LD; Cheng YW; Li LY; Xu LY; Li EM
Cell Death Differ; 2023 Feb; 30(2):527-543. PubMed ID: 36526897
[TBL] [Abstract][Full Text] [Related]
7. The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis.
Wang X; Xia S; Li H; Wang X; Li C; Chao Y; Zhang L; Han C
Cell Death Differ; 2020 Jun; 27(6):1747-1764. PubMed ID: 31748695
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
9. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma.
Radulovich N; Pham NA; Strumpf D; Leung L; Xie W; Jurisica I; Tsao MS
Mol Cancer; 2010 Feb; 9():24. PubMed ID: 20113529
[TBL] [Abstract][Full Text] [Related]
11. c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation.
Rhee K; Bresnahan W; Hirai A; Hirai M; Thompson EA
Cancer Res; 1995 Sep; 55(18):4188-95. PubMed ID: 7664296
[TBL] [Abstract][Full Text] [Related]
12. USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2.
Ouchida AT; Kacal M; Zheng A; Ambroise G; Zhang B; Norberg E; Vakifahmetoglu-Norberg H
Biochem Biophys Res Commun; 2018 Aug; 502(4):429-434. PubMed ID: 29803676
[TBL] [Abstract][Full Text] [Related]
13. USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation.
Lin Z; Yang H; Tan C; Li J; Liu Z; Quan Q; Kong S; Ye J; Gao B; Fang D
Cell Rep; 2013 Dec; 5(6):1639-49. PubMed ID: 24332849
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells.
Reisman D; Thompson EA
Mol Endocrinol; 1995 Nov; 9(11):1500-9. PubMed ID: 8584027
[TBL] [Abstract][Full Text] [Related]
15. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
16. Estrogen prevents cellular senescence and bone loss through Usp10-dependent p53 degradation in osteocytes and osteoblasts: the role of estrogen in bone cell senescence.
Wei Y; Fu J; Wu W; Ma P; Ren L; Wu J
Cell Tissue Res; 2021 Nov; 386(2):297-308. PubMed ID: 34223980
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinase ubiquitin-specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma.
Liu X; Chen B; Chen J; Su Z; Sun S
Cancer Sci; 2022 May; 113(5):1868-1879. PubMed ID: 35271750
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.
Xu Y; Xu M; Tong J; Tang X; Chen J; Chen X; Zhang Z; Cao B; Stewart AK; Moran MF; Wu D; Mao X
Blood; 2021 Mar; 137(11):1478-1490. PubMed ID: 32842143
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity.
Han Y; Yun CC
FASEB J; 2020 Dec; 34(12):16476-16488. PubMed ID: 33095475
[TBL] [Abstract][Full Text] [Related]
20. USP10 regulates p53 localization and stability by deubiquitinating p53.
Yuan J; Luo K; Zhang L; Cheville JC; Lou Z
Cell; 2010 Feb; 140(3):384-96. PubMed ID: 20096447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]